weekly injections
Despite extensive preclinical support, clinical trials of these agents have yielded largely inconsistent and disappointing outcomes (summarized in Table 1), highlighting fundamental translational challenges
They also are expensive and sometimes hard to get
These categories were based on the metabolic pathways that often share pathogenetic mechanisms, have similar clinical presentations, and are often recognized by the same diagnostic methodology
The duration of treatment is a decision made between you and your medical provider based on your health goals, progress, and tolerance of the medication
PlexusDx exclusively partners with licensed 503A compounding pharmacies, offering semaglutide ($189/mo), tirzepatide ($289/mo), oral formulations, and combination protocols